Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04587518 · ClinicalTrials.gov registry record · NA
Five Factor Model Treatment for Borderline Personality Disorder
A NA study, sponsored by Shannon E. Sauer-Zavala.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT04587518 is a NA study that has completed, run by Shannon E. Sauer-Zavala. The registered enrollment target is 100 participants.
The verdict
NCT04587518, a NA study, has completed, sponsored by Shannon E. Sauer-Zavala.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The primary purpose of this study is to explore acceptability, feasibility, and preliminary efficacy of a novel cognitive-behavioral treatment for borderline personality disorder (BPD). Extant treatments for this condition are intensive, long-term (usually at least one year), and have, understandably, focused on targeting the life-threatening and therapy-interrupting behaviors that often characterize this disorder. BPD, however, is a heterogeneous disorder with diagnostic criteria that can be combined to create over 300 unique symptom presentations (Ellis, Abrams, \& Abrams, 2008); to date, no treatments have been explicitly designed with lower risk presentations of BPD in mind. This is unfortunate, as there is evidence to suggest that the majority of individuals with BPD do not demonstrate the recurrent life-threatening behaviors that warrant intensive, long-term care (Trull, Useda, Conforti, \& Doan, 1997; Zimmerman \& Coryell, 1989). Additionally, various studies have shown that the difficulties experienced by individuals with BPD can be understood as manifestations of maladaptive variants of personality traits (e.g., Mullins-Sweatt et al., 2012). Specifically, individuals with BPD demonstrate high levels of neuroticism, and low levels of agreeableness (antagonism) and conscientiousness (disinhibition); these traits may not be universally present across all individuals with BPD, perhaps underscoring the heterogeneity in presentations of this condition.
Interventions
- BEHAVIORAL Personality-Based Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-09-03 |
| Est. Completion | 2024-05-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04587518
The ClinicalTrials.gov registry entry for NCT04587518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shannon E. Sauer-Zavala, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Personality-Based Cognitive Behavioral Therapy is the first listed.
NCT04587518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04587518 about?
NCT04587518 is a clinical study titled "Five Factor Model Treatment for Borderline Personality Disorder". The primary purpose of this study is to explore acceptability, feasibility, and preliminary efficacy of a novel cognitive-behavioral treatment for borderline personality disorder (BPD). Extant treatments for this condition are intensive, long-term (usually at least one year), and have, understandabl...
What is the current status of trial NCT04587518?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-09-03. Estimated completion is 2024-05-03.
What interventions are being tested in trial NCT04587518?
The interventions under investigation include: Personality-Based Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04587518?
This trial is sponsored by Shannon E. Sauer-Zavala, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.